Method for obtaining mouse hepatic stellate cells

By perfusion and density gradient centrifugation of mice liver in vitro, the problems of time-consuming and high requirements for separation of stellate cells in the existing technology were solved, and efficient and rapid acquisition of high-purity stellate cells was achieved. Cells are suitable for subsequent cell analysis and culture.

CN118909923APending Publication Date: 2024-11-08SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411153167.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The experimental conditions of the isolation method of mouse liver stellate cells in the prior art have high requirements, long time, and can only be isolated alone, affecting cell viability and gene expression.

Method used

Extracorporeal mouse liver was perfusion until the liver turned white, then cut and digested in the digestive fluid. After filtering, the intermediate white layer cells were isolated by centrifugation through density gradient to obtain mouse liver stellate cells.

Benefits of technology

It shortens the separation time, improves cell yield and purity, is simple and easy to operate, is suitable for continuous or simultaneous operation of multiple mice, and is suitable for subsequent cell analysis and culture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909923A_ABST
    Figure CN118909923A_ABST
Patent Text Reader

Abstract

The invention discloses a method for obtaining mouse hepatic stellate cells, and belongs to the technical field of hepatic stellate cell obtaining. I-type collagenase digestive juice is poured into the liver of an in-vitro mouse until the liver becomes white, and while the liver is flushed, the liver tissue is loosened, so that hepatic stellate cells are easily digested from a Disse cavity between sinus endothelial cells and hepatic cells; cutting the white liver in collagenase protease digestive juice, and further digesting in a shaking table to obtain digested liver tissues; and filtering the digested liver tissues, collecting filtrate, centrifuging, removing supernatant, washing cells, centrifuging, removing supernatant, performing density gradient centrifugation, and taking middle white layer cells, thereby obtaining the mouse hepatic stellate cells. The hepatic stellate cells separated through the method are high in purity and good in cell growth state, most adherent cells are hepatic stellate cells, and the method is expected to be a method for rapidly and efficiently separating the mouse hepatic stellate cells when many experimental samples exist.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of obtaining hepatic stellate cells, and in particular relates to a method for obtaining mouse hepatic stellate cells. Background Art

[0002] Liver fibrosis is a pathological change caused by chronic liver damage caused by various reasons. It is characterized by excessive and abnormal deposition of extracellular matrix components in the liver, which in turn affects liver function. It is an inevitable stage for chronic liver disease to develop into cirrhosis. However, there are currently few effective anti-fibrotic drugs for the treatment of liver fibrosis in clinical practice. In the late stage of liver fibrosis, the only treatment is liver transplantation. Therefore, it is necessary to explore new treatment methods or therapeutic drugs to prevent the further development of early liver fibrosis, or reverse the process of liver fibrosis and achieve the remission of liver fibrosis. To find new therapeutic targets and drugs, it is necessary to understand the mechanisms that lead to the development of liver fibrosis. The complex process of liver fibrosis is regulated by a variety of cells and cytokines. Among them, hepatic stellate cells (HSC) play an important role in the occurrence and development of liver fibrosis. The continuous activation of HSC leads to the further development of liver fibrosis. HSC is a resident cell in the liver. HSC is usually in a quiescent, non-proliferative state. However, when the liver is damaged, HSC transforms into a proliferative HSC. Myofibroblasts (MFs) derived from HSC are the main producers of fibrous matrix accumulated with the development of cirrhosis. Therefore, most of the research on the occurrence and development mechanism and treatment strategies of liver fibrosis is focused on this cell type.

[0003] At present, the main method of isolating hepatic stellate cells is to first perfuse the mouse liver in vivo and then remove the liver to obtain hepatic stellate cells. However, in vivo perfusion takes a long time, requires high experimental conditions, and can only be isolated individually. Therefore, in addition to being limited by experimental conditions, the isolation of mouse hepatic stellate cells is usually also limited by quantity and time. Longer isolation time will affect the viability, state, and gene expression of stellate cells. Summary of the invention

[0004] In order to overcome the above-mentioned shortcomings of the prior art, the purpose of the present invention is to provide a method for obtaining mouse hepatic stellate cells, so as to solve the technical problems that the current hepatic stellate cell isolation method has high experimental conditions, is time-consuming, and can only isolate a single hepatic stellate cell.

[0005] In order to achieve the above object, the present invention adopts the following technical solutions:

[0006] The first aspect of the present invention discloses a method for obtaining mouse hepatic stellate cells, comprising the following steps:

[0007] 1) perfusing an isolated mouse liver until the liver turns white, thereby obtaining a whitened liver;

[0008] 2) chopping the blanched liver in digestive juice, digesting it, and obtaining digested liver tissue;

[0009] 3) Filter the digested liver tissue and collect the filtrate, centrifuge, remove the supernatant, wash the cells, perform density gradient centrifugation, take the middle white layer cells, and obtain mouse hepatic stellate cells.

[0010] Preferably, before step 1), the hepatic arteriovenous plexus of the isolated mouse liver is clamped.

[0011] Preferably, in step 1), the perfusion position is the middle part of each lobe of the isolated mouse liver.

[0012] Preferably, in step 1), perfusion is performed using a syringe, and the syringe is inserted to a depth of 1 / 2 of the thickness of the liver lobe.

[0013] Preferably, in step 1), the perfusion fluid is type I collagenase digestion fluid; the preparation method of type I collagenase digestion fluid is: add 1190 mg of HEPES and 280 mg of Cacl2 to every 500 mL of HBSS buffer and mix well to obtain tissue digestion buffer; add 5 mg of collagenase I to every 10 mL of tissue digestion buffer to obtain type I collagenase digestion fluid.

[0014] Preferably, the perfusion solution during perfusion in step 1) and the digestion solution in step 2) are both preheated at 40° C. before use.

[0015] Preferably, in step 2), the digestion solution used is a collagenase protease digestion solution; the preparation method of the collagenase protease digestion solution is as follows: 1190 mg of HEPES and 280 mg of Cacl2 are added to every 500 mL of HBSS buffer and mixed to obtain a tissue digestion buffer; 5 mg of collagenase I is added to every 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution; 4 mg of protease is added to every 10 mL of type I collagenase digestion solution to obtain a collagenase protease digestion solution.

[0016] Preferably, in step 2), the shredded and blanched liver tissue is placed in a collagenase protease DNase digestion solution and digested on a shaker; the preparation method of the collagenase protease DNase digestion solution is as follows: 1190 mg of HEPES and 280 mg of Cacl2 are added to every 500 mL of HBSS buffer and mixed to obtain a tissue digestion buffer; 5 mg of collagenase I is added to every 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution; 4 mg of protease is added to every 10 mL of type I collagenase digestion solution to obtain a collagenase protease digestion solution; 10 mL of GBSS is added to every 20 mg of DNase I and mixed to obtain a DNase I solution; 100 μL of DNase I solution is added to every 10 mL of collagenase protease digestion solution to obtain a collagenase protease DNase digestion solution.

[0017] Preferably, in step 3), the digested liver tissue is filtered through a 70 μm filter.

[0018] The second aspect of the present invention discloses the application of the above method in the study of liver fibrosis.

[0019] Compared with the prior art, the present invention has the following beneficial effects:

[0020] The present invention provides a method for obtaining mouse hepatic stellate cells, 1) first remove the mouse liver, and then perform perfusion separation of mouse primary hepatic stellate cells in an ex vivo state of the liver. This method takes a short time for perfusion, and is not prone to the problem of reduced cell viability caused by long-term experimental operation. A high-yield single-cell suspension can be obtained in a short time, thereby providing a basis for long-term in vitro culture of primary hepatic stellate cells. 2) Since hepatic stellate cells contain a large number of lipid droplets, after digesting the liver tissue, hepatic stellate cells can be easily separated from other liver cell groups based on a density gradient centrifugation method. The entire method is simple and easy to operate. Compared with the conventional in vivo perfusion separation to obtain hepatic stellate cells, which takes more than 4 hours to complete, this method takes about two hours to complete, shortening the time by half or more, and this operation can be performed continuously or simultaneously on multiple mice, which allows the rapid separation of mouse hepatic stellate cells when a large number of animals are required for the experiment, facilitating subsequent analysis and culture experiments. By culturing the hepatic stellate cells obtained by this method until they adhere to the wall and then testing, it is proved that mouse hepatic stellate cells can be successfully isolated, and the isolated hepatic stellate cells have high purity, high yield, and good cell growth state. Most of the cells that adhere to the wall are hepatic stellate cells. It is expected to become a method for quickly and efficiently isolating mouse hepatic stellate cells when there are many experimental samples. Subsequent analysis and culture and other related experiments can be carried out for promotion and use in related scientific research, greatly expanding the application field of primary hepatic stellate cells.

[0021] Furthermore, clamping the hepatic arteriovenous plexus of mice before perfusion can reduce fluid reflux.

[0022] Furthermore, injection is performed in the middle of each lobe of the isolated liver to ensure that the perfusion fluid is evenly distributed throughout the organ, facilitating thorough digestion.

[0023] Furthermore, by injecting type I collagenase digestion solution into the liver, it is possible to ensure that the liver red blood cells are flushed while the liver tissue is loosened, making it easy for the hepatic stellate cells to be digested out of the Disse cavity between the sinusoidal endothelial cells and the hepatocytes.

[0024] Furthermore, the bleached liver is cut into pieces in a collagenase protease digestion solution, and the hepatic stellate cells are separated from the liver using a combined enzymatic hydrolysis method of protease and collagenase. This shortens the experimental time while obtaining hepatic stellate cells with a higher yield and purity. The operation is simple and efficient. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 The fluorescence microscope observation images of the hepatic stellate cells separated and attached to the wall obtained by the present invention are shown in Figure 1; wherein A is a bright field image of the cells, and B is an autofluorescence image of the cells;

[0026] Figure 2 The immunofluorescence images of the hepatic stellate cells separated and obtained in the present invention are marked with DAPI and a-SMA; wherein A is DAPI-stained nuclei, and B is α-SMA-marked. DETAILED DESCRIPTION

[0027] In order to enable those skilled in the art to understand the characteristics and effects of the present invention, the following is a general description and definition of the terms and expressions mentioned in the specification and claims. Unless otherwise specified, all technical and scientific terms used in the text are the common meanings understood by those skilled in the art for the present invention. In the event of a conflict, the definition in this specification shall prevail.

[0028] The theories or mechanisms described and disclosed herein, whether correct or incorrect, should not limit the scope of the present invention in any way, that is, the present invention can be implemented without being limited by any specific theory or mechanism.

[0029] Herein, all features such as values, quantities, contents and concentrations defined in the form of numerical ranges or percentage ranges are for simplicity and convenience only. Accordingly, the description of numerical ranges or percentage ranges should be considered to have included and specifically disclosed all possible secondary ranges and individual values ​​within the range (including integers and fractions).

[0030] In this document, unless otherwise specified, “includes,” “including,” “contains,” “has,” or similar terms cover the meanings of “consisting of” and “mainly consisting of,” for example, “A includes a” covers the meanings of “A includes a and other” and “A only includes a.”

[0031] In this document, in order to make the description concise, not all possible combinations of various technical features in various embodiments or examples are described. Therefore, as long as there is no contradiction in the combination of these technical features, the various technical features in various embodiments or examples can be combined arbitrarily, and all possible combinations should be considered to be within the scope of this specification.

[0032] In this article, the preparation method of the solution involved is:

[0033] Type I collagenase digestion solution: Add 1190 mg of HEPES (Beyotime, ST090-100g) and 280 mg of CaCl2 to 500 mL of HBSS (Hanks' Balanced Salt Solution, Beyotime, Catalog No. C0218) buffer, mix well, and preheat in a water bath to obtain tissue digestion buffer. Add 5 mg of collagenase I (Sigma-Aldrich, C0130-1G) to each 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution. Preheat at 40°C and set aside.

[0034] Collagenase protease digestion solution: Add 4 mg of protease (Sigma-Aldrich, P5147-1G) to every 10 mL of type I collagenase digestion solution to obtain collagenase protease digestion solution. Preheat to 40°C and set aside.

[0035] DNase I solution: Add 20 mg DNase I (Roche, 10104159001) to 10 mL GBSS (Gey's Balanced Salt Solution, Livning, C1076-A) and fully dissolve, then store at -20°C. When using, in order to dilute the DNase I solution to its working concentration, GBSS or other buffers, digestion solutions, etc. are required to further dilute the above DNase I solution to 100 times the original volume.

[0036] Collagenase protease DNase digestion solution: Add 100 μL DNase I solution to every 10 mL of collagenase protease digestion solution to obtain collagenase protease DNase digestion solution.

[0037] GBSB solution: Add 4 g NaCl to every 500 mL GBSS solution and fully dissolve to obtain GBSB solution.

[0038] Prepare Nycodenz solution: dissolve 4.94 g Nycodenz (Serumwerk, 18003) in 15 mL GBSS solution, and make up to 17 mL with GBSS solution. Prepare and use immediately.

[0039] The present invention provides a method for obtaining mouse hepatic stellate cells, comprising the following steps:

[0040] 1. Mouse Liver Perfusion

[0041] The needle was inserted into the middle part of each lobe of the isolated mouse liver at a depth of about 1 / 2, and type I collagenase digestion solution was perfused until the liver turned white, thereby obtaining a whitened mouse liver.

[0042] 2. Mouse Liver Digestion

[0043] Cut the whitened mouse liver into pieces in collagenase protease digestion solution so that the protease and collagenase can fully digest the tissue and release the target cells. Transfer the cut mouse liver tissue to a 50mL centrifuge tube filled with collagenase protease DNase digestion solution and digest it on a shaker to obtain the digested mouse liver tissue.

[0044] 3. Isolation of Mouse Hepatic Stellate Cells

[0045] The digested liver tissue was filtered and the filtrate was collected, centrifuged, the supernatant was removed, the cells were washed, density gradient centrifuged, the white layer was taken, centrifuged, and the cells were washed to obtain mouse hepatic stellate cells.

[0046] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.

[0047] The following examples use conventional instruments and equipment in the art. The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or under conditions recommended by the manufacturer. The various raw materials used in the following examples, unless otherwise specified, are conventional commercial products, and their specifications are conventional specifications in the art.

[0048] 1. Obtaining Mouse Hepatic Stellate Cells

[0049] 1. Preparation

[0050] 1) Preheat type I collagenase digestion solution and collagenase protease digestion solution at 40°C respectively;

[0051] 2) The mice were anesthetized with an intraperitoneal injection of 0.1 mg ketamine + 0.01 mg xylazine per gram of body weight per mouse. After the mice were anesthetized, the abdomen was cut open and the liver was fully exposed.

[0052] 2. Mouse Liver Perfusion

[0053] 1) Cut open the inferior vena cava of mice to bleed to reduce the blood flow to the liver;

[0054] 2) Cut the mouse liver and try to keep the liver intact;

[0055] 3) Clamp the mouse's hepatic arteriovenous plexus with forceps or hemostats to reduce fluid reflux;

[0056] 4) Use a 5 mL syringe and a 30G syringe needle to draw up type I collagenase solution (Sigma-Aldrich, C0130-1G). Insert the needle 1 / 2 into the middle of each lobe of the isolated mouse liver for liver perfusion. The amount of type I collagenase digestion solution required for each lobe of the liver is approximately 1.2 mL, or until the liver turns obviously white when observed with the naked eye. The perfusion of each lobe of the liver takes about 10 seconds each time, and a total of about 50 seconds.

[0057] 3. Mouse Liver Digestion

[0058] 1) Place the mouse liver after perfusion in step 2 into a 6-well plate containing collagenase protease digestion solution;

[0059] 2) Grasp the mouse liver with forceps, tear off the liver capsule, gallbladder and other redundant tissues, and use scissors to fully chop the mouse liver until no obvious tissue blocks can be seen with the naked eye. This step takes about 2 minutes;

[0060] 3) Transfer the chopped mouse liver tissue into a 50 mL centrifuge tube containing 20 mL collagenase protease DNase digestion solution, shake at 40°C, 150 rpm, and digest for 30 minutes. If the mouse has liver fibrosis, increase the collagenase concentration to 1.5 times the original collagenase and digest for 30 minutes.

[0061] 4. Isolation of Mouse Hepatic Stellate Cells

[0062] 1) Filtration: Filter the cells with a 70 μm filter and collect the cell filtrate; gently press and grind the remaining undigested tissue with a 5 mL syringe needle plug; centrifuge at 500 g, 4°C for 10 min;

[0063] 2) After the cells are centrifuged, remove the supernatant (retain 10 mL) and add GBSB solution to 50 mL; add 500 μL DNase I solution to prevent cell adhesion, centrifuge at 500g at 4℃ for 10 min; wash the cells once. Retain 10 mL of supernatant to resuspend the cells, add 500 μL DNase I solution, and replenish the volume of GBSB solution to 50 mL; centrifuge at 500g at 4℃ for 10 min, wash the cells again, and retain 10 mL of supernatant to resuspend the cells after centrifugation.

[0064] 3) Add 500 μL of DNase I solution, then add GBSB solution to 32 mL, mix with 16 mL of Nycodenz solution, and dispense into four 15 mL centrifuge tubes to fully wet the tube walls.

[0065] 4) Use a 2.5 mL syringe with an 18G syringe needle to slowly overlay 1.5 mL of GBSB solution on the solution in step 3), centrifuge at 1380 g, 4°C for 17 min, increase by 2 and decrease by 1; after centrifugation, the cells will be divided into three layers, and the middle white layer is the layer where the hepatic stellate cells are located;

[0066] 5) Collect the hepatic stellate cell layer with a 5 mL Pasteur pipette (avoid sucking other miscells) and transfer to a new 15 mL centrifuge tube; add GBSB solution to 15 mL, centrifuge at 500 g, 4 ° C for 10 min; keep 1 mL of supernatant to resuspend the cells, add GBSB solution to 15 mL, wash the cells again, centrifuge at 500 g, 4 ° C for 10 min; culture with DMEM containing 10% FBS and 4% antibiotics.

[0067] 2. Autofluorescence Verification of Mouse Hepatic Stellate Cells

[0068] After the separated cells are completely attached to the wall, the supernatant is discarded and the DAPI fluorescence channel is selected: excitation 360 / 45nm, emission 410nm LP for observation under a fluorescence microscope.

[0069] Observation results such as Figure 1 As shown, under the conditions of excitation wavelength 360 / 45nm and emission wavelength 410nm, the separated cells can be observed to have the characteristics of spontaneous fluorescence through fluorescence microscopy, which is consistent with the characteristics of hepatic stellate cells, indicating that this method can be used to isolate stellate cells from mouse liver.

[0070] 3. Hepatic stellate cell immunofluorescence experiment

[0071] 1. Before paving cells, pre-spread cell slides, add corresponding complete culture medium, and dropwise add cell suspension;

[0072] 2. After 7 days of complete cell attachment, the mouse hepatic stellate cells were assumed to be activated and the cells were washed 3 times with PBS;

[0073] 3. Fixation: 4% paraformaldehyde fully covers the cells, fix at room temperature for 15 minutes, and wash with PBST for 5 minutes × 3 times;

[0074] 4. Permeabilization: Cover the cells with 0.2% Triton X-100 and incubate at room temperature for 20 minutes, then wash with PBST for 5 minutes × 3 times;

[0075] 5. Blocking: Place the slices in a humidified box, completely cover the samples with 5% BSA, and incubate at room temperature for 30 minutes.

[0076] 6. Primary antibody incubation: Select a primary antibody for α-SMA that can be used for IF, dilute the primary antibody with 5% BSA, mix well and cover the sample, incubate overnight at 4°C; rewarm at room temperature for 20 minutes the next day, wash with PBST for 5 minutes × 3 times;

[0077] 7. Secondary antibody incubation: dilute the secondary antibody as recommended in the instructions, incubate at room temperature in the dark for 1 hour, then wash with PBST for 5 minutes × 3 times;

[0078] 8. DAPI nuclear staining / sealing: Use absorbent paper to absorb the residual liquid on the slice, drop DAPI anti-quenching sealing agent on the slice, cover with a coverslip to avoid bubbles;

[0079] 9. Film reading: Use a fluorescence microscope to take pictures and collect images.

[0080] The experimental results are as follows Figure 2 As shown, the isolated hepatic stellate cells can express α-SMA, a characteristic marker of stellate cells, which further proves that this method can be used to isolate stellate cells from mouse liver.

[0081] The above contents are only for explaining the technical idea of ​​the present invention and cannot be used to limit the protection scope of the present invention. Any changes made on the basis of the technical solution in accordance with the technical idea proposed by the present invention shall fall within the protection scope of the claims of the present invention.

Claims

1. A method for obtaining mouse hepatic stellate cells, characterized in that: The following steps are involved: 1) perfusing an isolated mouse liver until the liver turns white, thereby obtaining a whitened liver; 2) chopping the blanched liver in digestive juice, digesting it, and obtaining digested liver tissue; 3) Filter the digested liver tissue and collect the filtrate, centrifuge, remove the supernatant, wash the cells, perform density gradient centrifugation, take the middle white layer cells, and obtain mouse hepatic stellate cells.

2. A method for obtaining mouse hepatic stellate cells according to claim 1, characterized in that: Prior to step 1), the hepatic arteriovenous plexus of the isolated mouse liver was clamped.

3. The method for obtaining mouse hepatic stellate cells according to claim 1, characterized in that: In step 1), the perfusion position is the middle part of each lobe of the isolated mouse liver.

4. The method for obtaining mouse hepatic stellate cells according to claim 1, characterized in that: In step 1), perfusion is performed using a syringe, and the syringe is inserted to a depth of 1 / 2 of the thickness of the liver lobe.

5. The method for obtaining mouse hepatic stellate cells according to claim 1, characterized in that: In step 1), the perfusion fluid is type I collagenase digestion solution; the preparation method of type I collagenase digestion solution is: add 1190 mg of HEPES and 280 mg of CaCl2 to every 500 mL of HBSS buffer and mix well to obtain tissue digestion buffer; add 5 mg of collagenase I to every 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution.

6. The method for obtaining mouse hepatic stellate cells according to claim 5, characterized in that: The perfusion solution in step 1) and the digestion solution in step 2) are both preheated at 40° C. before use.

7. The method for obtaining mouse hepatic stellate cells according to claim 1, characterized in that: In step 2), the digestion solution used is collagenase protease digestion solution; the preparation method of collagenase protease digestion solution is as follows: 1190 mg of HEPES and 280 mg of Cacl2 are added to every 500 mL of HBSS buffer and mixed to obtain tissue digestion buffer; 5 mg of collagenase I is added to every 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution; 4 mg of protease is added to every 10 mL of type I collagenase digestion solution to obtain collagenase protease digestion solution.

8. The method for obtaining mouse hepatic stellate cells according to claim 1, characterized in that: In step 2), the shredded and blanched liver tissue is placed in a collagenase protease DNase digestion solution and digested on a shaker; the preparation method of the collagenase protease DNase digestion solution is as follows: 1190 mg of HEPES and 280 mg of Cacl2 are added to every 500 mL of HBSS buffer and mixed to obtain a tissue digestion buffer; 5 mg of collagenase I is added to every 10 mL of tissue digestion buffer to obtain type I collagenase digestion solution; 4 mg of protease is added to every 10 mL of type I collagenase digestion solution to obtain a collagenase protease digestion solution; 10 mL of GBSS is added to every 20 mg of DNase I and mixed to obtain a DNase I solution; 100 μL of DNase I solution is added to every 10 mL of collagenase protease digestion solution to obtain a collagenase protease DNase digestion solution.

9. The method for obtaining mouse hepatic stellate cells according to claim 1, characterized in that: In step 3), the digested liver tissue is filtered through a 70 μm filter.

10. Use of the method according to any one of claims 1 to 9 in the study of liver fibrosis.